drugs.com vs TrimRx
Market traction comparison · Updated Jul 2026
| drugs.com | TrimRx | Leads | |
|---|---|---|---|
| Monthly Visits | 18.9M | 3.6M | drugs.com |
| Bounce Rate | 58.5% | 57.9% | TrimRx |
| Domain Rating | — | 60 | |
| Est. MRR | — | $249.2K | |
| SEO & Keywords | 30 | 35 | TrimRx |
| Domain Age | 27y 8m | 7y 1m | drugs.com |
drugs.com leads in 2 of 4 dimensions, while TrimRx leads in 2.
Growth Momentum
| drugs.com | TrimRx | Leads | |
|---|---|---|---|
| Monthly Visits | 18.9M | 3.6M | drugs.com |
| MoM Change | +11% | -16% | drugs.com |
| Avg. Session | 1m56s | 2m13s | TrimRx |
| Pages / Visit | 2.4 | 5.1 | TrimRx |
Growth Momentum · Insight
TrimRx is losing traffic (-16%) despite 3.6M monthly visits. drugs.com's +11% growth puts it on a trajectory to overtake.
Acquisition Strategy
| drugs.com | TrimRx | Leads | |
|---|---|---|---|
| Primary Channel | Search 69% | Direct 35% | |
| Bounce Rate | 58.5% | 57.9% | TrimRx |
| SEO & Keywords | 30 | 35 | TrimRx |
Keyword Overlap Rate: 16%
Acquisition Strategy · Insight
drugs.com acquires users primarily through Search (69%), while TrimRx relies on Direct (35%). This reflects fundamentally different go-to-market strategies — TrimRx's higher direct traffic suggests stronger brand recognition or product-led growth, while drugs.com's search reliance means growth is more scalable but more vulnerable to algorithm changes.
Business Maturity
Revenue estimates are derived from public data sources. Actual figures may differ.
| drugs.com | TrimRx | Leads | |
|---|---|---|---|
| Est. MRR | — | $249.2K | |
| Revenue / Visit | — | $0.069 | |
| Domain Age | 27y 8m | 7y 1m | drugs.com |
| Registered | Dec 1998 | Jul 2019 | |
| Expires | Dec 2026 | Jul 2034 |
Business Maturity · Insight
TrimRx has reached $249.2K MRR in 7 years while drugs.com shows no public revenue data after 28 years — suggesting different monetization maturity or disclosure strategies.
Market Position
| drugs.com | TrimRx | Leads | |
|---|---|---|---|
| Domain Rating | — | 60 | |
| Global Rank | #3.4K | #12.9K | drugs.com |
| Category Rank | #3 | #7 | drugs.com |
drugs.com only
TrimRx only
Market Position · Insight
Each has untapped markets the other serves: drugs.com could expand into Brazil, while TrimRx could target Colombia.
Key Takeaways
- •TrimRx is losing traffic (-16%) despite 3.6M monthly visits. drugs.com's +11% growth puts it on a trajectory to overtake.
- •drugs.com acquires users primarily through Search (69%), while TrimRx relies on Direct (35%). This reflects fundamentally different go-to-market strategies — TrimRx's higher direct traffic suggests stronger brand recognition or product-led growth, while drugs.com's search reliance means growth is more scalable but more vulnerable to algorithm changes.
- •drugs.com receives 5.2x more monthly traffic than TrimRx (18.9M vs 3.6M).
- •drugs.com is growing (+11%) while TrimRx is declining (-16%).
- •drugs.com acquires traffic primarily through Search (69%), while TrimRx relies on Direct (35%) — fundamentally different acquisition strategies.
- •They share 9 keywords (16% overlap), indicating direct search competition.
You've seen the gap. Now steal the playbook.
A Growth Teardown reverse-engineers exactly how each product grows — traffic sources, backlink strategy, keyword gaps, and scored action items you can copy this week.
Related Comparisons
Report based on data from July 2026